Similar articles for PMID: 34911831

Year	Number of Results
1984	1
1986	2
1994	1
1995	1
1996	2
1998	3
1999	2
2000	2
2002	5
2003	4
2004	2
2006	3
2007	5
2008	6
2009	3
2010	3
2012	5
2013	1
2014	3
2015	4
2016	8
2017	6
2018	12
2019	8
2020	7
2021	15
2022	3

1

Proceedings of 2019 Viral Clearance Symposium, Session 5: Viral Inactivation.

Ma J. Ma J. PDA J Pharm Sci Technol. 2021 Dec 15:pdajpst.2021.012681. doi: 10.5731/pdajpst.2021.012681. Online ahead of print. PDA J Pharm Sci Technol. 2021. PMID: 34911831

2

Evaluation of eco-friendly zwitterionic detergents for enveloped virus inactivation.

Conley L, Tao Y, Henry A, Koepf E, Cecchini D, Pieracci J, Ghose S. Conley L, et al. Biotechnol Bioeng. 2017 Apr;114(4):813-820. doi: 10.1002/bit.26209. Epub 2016 Nov 9. Biotechnol Bioeng. 2017. PMID: 27800626

3

Assessing detergent-mediated virus inactivation, protein stability, and impurity clearance in biologics downstream processes.

Feroz H, Chennamsetty N, Byers S, Holstein M, Li ZJ, Ghose S. Feroz H, et al. Biotechnol Bioeng. 2022 Apr;119(4):1091-1104. doi: 10.1002/bit.28034. Epub 2022 Feb 8. Biotechnol Bioeng. 2022. PMID: 35023152

4

Proceedings of the 2017 Viral Clearance Symposium Session 5: Facility Risk Mitigation.

Ma J, Kreil TR. Ma J, et al. PDA J Pharm Sci Technol. 2018 Sep-Oct;72(5):511-515. doi: 10.5731/pdajpst.2018.009175. Epub 2018 Jul 20. PDA J Pharm Sci Technol. 2018. PMID: 30030359

5

Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates.

Korneyeva M, Hotta J, Lebing W, Rosenthal RS, Franks L, Petteway SR Jr. Korneyeva M, et al. Biologicals. 2002 Jun;30(2):153-62. doi: 10.1006/biol.2002.0334. Biologicals. 2002. PMID: 12127317

6

Identification and characterization of a Triton X-100 replacement for virus inactivation.

Luo W, Hickman D, Keykhosravani M, Wilson J, Fink J, Huang L, Chen D, O'Donnell S. Luo W, et al. Biotechnol Prog. 2020 Nov;36(6):e3036. doi: 10.1002/btpr.3036. Epub 2020 Jul 6. Biotechnol Prog. 2020. PMID: 32533632

7

Proceedings of the 2017 Viral Clearance Symposium, Session 2.1: DSP Unit Operations-Virus Filtration/Inactivation.

Kreil TR, Roush D. Kreil TR, et al. PDA J Pharm Sci Technol. 2018 Sep-Oct;72(5):470-478. doi: 10.5731/pdajpst.2018.009118. Epub 2018 Jul 20. PDA J Pharm Sci Technol. 2018. PMID: 30030356

8

Inactivation of viruses using novel protein A wash buffers.

Bolton GR, Selvitelli KR, Iliescu I, Cecchini DJ. Bolton GR, et al. Biotechnol Prog. 2015 Mar-Apr;31(2):406-13. doi: 10.1002/btpr.2024. Epub 2014 Dec 19. Biotechnol Prog. 2015. PMID: 25482293

9

Proceedings of the 2017 Viral Clearance Symposium, Session 6: Ensuring Viral Safety in Continuous Processing.

Johnson SA, Roush D. Johnson SA, et al. PDA J Pharm Sci Technol. 2018 Sep-Oct;72(5):516-524. doi: 10.5731/pdajpst.2018.009183. Epub 2018 Jul 20. PDA J Pharm Sci Technol. 2018. PMID: 30030352

10

Proceedings of 2019 Viral Clearance Symposium, Session 1: Viral Clearance Strategies and Case Studies.

Reitz S, Schwantes A. Reitz S, et al. PDA J Pharm Sci Technol. 2021 Dec 15:pdajpst.2021.012677. doi: 10.5731/pdajpst.2021.012677. Online ahead of print. PDA J Pharm Sci Technol. 2021. PMID: 34911829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed